Anti-aging pill? singapore trial tests AKG on biological age
NCT ID NCT05706389
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking alpha-ketoglutarate (AKG), a natural substance in the body, can lower biological age in 120 middle-aged adults from Singapore. Participants must have a biological age older than their actual age. The study measures changes in DNA methylation (a marker of aging) and other health indicators over 6 months. It aims to see if aging can be slowed down with a simple supplement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre for Healthy Longevity, Alexandra Hospital
Singapore, 159964, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- The aging Body's hidden water shift: a new study investigates
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Can a simple walk test reveal hidden health risks in aging?
- A handful of walnuts a day: could it keep the aging mind sharp?
- Shining a light on brain aging: could NIR boost memory?